REGULATORY

Panel OKs 37 More COVID-19 Jab Health Damage Claims for Compensation

September 14, 2021

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

A health ministry panel on September 13 approved 37 additional health damage claims following COVID-19 vaccinations for compensation, putting them in line to receive medical benefits, subject to the health minister’s approval. All 37 claims submitted for the day’s review…

To read the full story

MHLW Panel OKs 192 More Health Damage Claims for COVID-19 Vaccines
April 24, 2023
Relief Claims OK’ed for 12 More Deaths Possibly Linked to COVID Jabs
April 18, 2023
MHLW Panel OKs 184 More Health Damage Claims for COVID-19 Jabs
March 22, 2023
Japan Damage Relief Panel Recognizes 11 More Deaths Possibly Tied to COVID Jabs
March 16, 2023
Japan Panel Recognizes 10 More Deaths Possibly Linked to COVID Jabs
February 13, 2023
MHLW Panel OKs 79 More Health Damage Claims for COVID-19 Vaccines
February 8, 2023
MHLW Panel OKs 62 More Health Damage Claims for COVID-19 Vaccines
January 24, 2023
MHLW Panel OKs 64 More Health Damage Claims for COVID-19 Vaccines
January 16, 2023
Japan Panel Recognizes 5 More Deaths Possibly Tied to COVID Vaccines
January 13, 2023
Japan to Boost Review of Health Damage Claims for COVID-19 Vaccines
January 12, 2023
MHLW Panel OKs 70 More Health Damage Claims for COVID-19 Vaccines
December 26, 2022
Japan Panel Recognizes 5 More Deaths Possibly Linked to COVID Jabs, 1st for 20s
December 13, 2022
MHLW Panel OKs 111 More Health Damage Claims for COVID-19 Vaccines
November 28, 2022
Japan Panel Recognizes 6 More Deaths Possibly Linked to COVID Vaccines
November 8, 2022
MHLW Panel OKs 100 More Health Damage Claims for COVID-19 Vaccines
October 31, 2022
Japan Panel Recognizes One More Death Possibly Linked to COVID Jab
October 18, 2022
MHLW Panel OKs 65 More Health Damage Claims for COVID-19 Vaccines
September 26, 2022
MHLW Panel Recognizes 2 More Deaths Linked to COVID Jabs
September 13, 2022
MHLW Panel OKs 60 More Health Damage Claims for COVID-19 Vaccines
July 29, 2022
Japan Panel Recognizes 1st Death Linked to COVID Vaccination
July 26, 2022
MHLW Panel OKs 56 More Health Damage Claims for COVID-19 Vaccines
June 27, 2022
MHLW Panel OKs 62 More Health Damage Claims for COVID-19 Vaccines
June 3, 2022
MHLW Panel OKs 84 More Health Damage Claims for COVID-19 Vaccines
March 28, 2022
MHLW OKs 48 More Health Damage Claims for COVID-19 Vaccines
February 28, 2022
MHLW OKs 115 More COVID-19 Vaccine Health Damage Claims
February 1, 2022
MHLW Panel OKs 81 More COVID-19 Vaccine Health Damage Claims
October 25, 2021
Japan Panel OKs COVID-19 Vaccine Health Damage Claims for First Time
August 20, 2021

REGULATORY

Japan Panel Backs Daiichi’s MMR Vaccine, Haihe’s PI3Kα Inhibitor, MSD’s HIV Med
March 3, 2026
MHLW Revises Guidance on Pediatric Development Plans under Amended PMD Act
March 3, 2026
MHLW Details New Operational Rules for Conditional Approvals from May
March 3, 2026
MHLW Seeks Sponsors to Develop 8 “Drug-Loss” Products
March 2, 2026
WG Members Urge Domestic Biologic Production as National Growth Strategy
March 2, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

G1 Rule to Hit Originator Biologics for First Time, Impact Seen for Up to 13 Brands

By Shinya Sato

Japan’s FY2026 drug pricing reform will, for the first time, apply the “G1” price cut rule for long-listed original biologics…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…